Back
Evolve Enhanced Yield Bond Fund Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
12
BOND.TO
Evolve Enhanced Yield Bond Fund
Last Price:
$17.42
Seasonality Move:
-3.05%
Sell
33
ZBIO
Zenas BioPharma, Inc.
Last Price:
$36.94
Seasonality Move:
-8.13%
Sell
12
Evolve Enhanced Yield Bond Fund (BOND.TO)
is a Sell
Is Evolve Enhanced Yield Bond Fund a Buy, Sell or Hold?
-
The current Evolve Enhanced Yield Bond Fund [BOND.TO] share price is $17.35. The Score for BOND.TO is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
BOND.TO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $32.59. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BOND.TO Stock Price Chart
What is Evolve Enhanced Yield Bond Fund's stock price today?
-
The Evolve Enhanced Yield Bond Fund share price today is $17.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BOND.TO is experiencing selling pressure, which indicates risk of future bearish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $32.59The current trend is moderately bullish and ZBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BOND.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 31.73 | Sell |
| Chaikin Money Flow: | -10315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.47 - 17.89) | Sell |
| Bollinger Bands (100): | (17.66 - 18.1) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.39 | Buy |
| Relative Strength Index (14 RSI): | 42.51 | Sell |
| Chaikin Money Flow: | -433025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.8 - 39.38) | Sell |
| Bollinger Bands (100): | (16.79 - 33.43) | Buy |
BOND.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.44 | Sell |
| 20-day SMA: | 17.65 | Sell |
| 50-day SMA: | 17.88 | Sell |
| 200-day SMA: | 18.02 | Sell |
| 8-day EMA: | 17.45 | Sell |
| 20-day EMA: | 17.6 | Sell |
| 50-day EMA: | 17.77 | Sell |
| 200-day EMA: | 18.16 | Sell |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.44 | Sell |
| 20-day SMA: | 37.66 | Sell |
| 50-day SMA: | 32.27 | Buy |
| 200-day SMA: | 17.45 | Buy |
| 8-day EMA: | 37.61 | Sell |
| 20-day EMA: | 34.32 | Sell |
| 50-day EMA: | 23.15 | Buy |
| 200-day EMA: | 7.97 | Buy |
Evolve Enhanced Yield Bond Fund Earnings Growth & BOND.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
Evolve Enhanced Yield Bond Fund Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||